Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 7
Submit an article Journal homepage
683
Views
4
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study

Isabelle FleuryHemato-Oncology, AP-HP at Saint-Louis Hospital, Paris VII Diderot- Sorbonne University, IUH, Paris, France
,
Sandy AmorimHemato-Oncology, AP-HP at Saint-Louis Hospital, Paris VII Diderot- Sorbonne University, IUH, Paris, France
,
Nicolas MounierOnco-Hematology, Archet University Hospital, Nice, France
,
Bertrand CoiffierHematology, Lyon Sud University Hospital, Pierre-Bénite, France
,
Jehan DupuisHematology, AP-HP at Henri Mondor University Hospital, Créteil, France
,
Hervè TillyHematology, Henri Becquerel Centre, Rouen, France
,
Mohamed A. MazariHematology, Lapeyronie University Hospital, Montpellier, France
,
Lauriane FilliatreHematology, Nancy University Hospital, Nancy, France
,
Josette BrièrePathology, AP-HP at Saint-Louis Hospital, Paris VII Diderot- Sorbonne University, IUH, Paris, France
,
Pauline BriceHemato-Oncology, AP-HP at Saint-Louis Hospital, Paris VII Diderot- Sorbonne University, IUH, Paris, France
,
Eric de KervilerRadiology, AP-HP at Saint-Louis Hospital, Paris VII Diderot- Sorbonne University, IUH, Paris, France
&
Catherine ThieblemontHemato-Oncology, AP-HP at Saint-Louis Hospital, Paris VII Diderot- Sorbonne University, IUH, Paris, FranceCorrespondence[email protected]
 show all
Pages 2025-2031 | Received 27 Jun 2014, Accepted 13 Oct 2014, Published online: 17 Dec 2014

References

  • Cugati G, Singh M, Symss NP, et al. Primary spinal intradural extramedullary lymphoma causing cauda equina syndrome. J Craniovertebr Junction Spine 2012;3:58–61.
  • Loblaw D, Perry J, Chambers A, et al. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol 2005;23:2028–37.
  • Thieblemont C, Gisselbrecht C. Second-line treatment paradigms for diffuse large B-cell lymphomas. Curr Oncol Rep 2009;11: 386–393.
  • Bashir R, Bierman P, Vose J, et al. Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma. Am J Clin Oncol 1991;14:478–482.
  • Kridel R, Dietrich P. Prevention of CNS relapse in diffuse large B-cell lymphoma. Lancet Oncol 2011;12:1258–1266.
  • Siegal T, Goldschmidt N. CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom? Blood Rev 2012;26:97–106.
  • National Comprehensive Cancer Network. Non-Hodgkin's lymphomas, 2. V. Available from: www.nccnorg/professionals/physician_gls/pdf/nhlpdf
  • Kaplan L. HIV-associated lymphoma. Best Pract Res Clin Haematol 2012;25:101–117.
  • Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
  • Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
  • Sebban C, Mounier N, Brousse N, et al. Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d’Etude des Lymphomes de l’Adulte (GELA). Blood 2006;108:2540–2544.
  • Monnard V, Sun A, Epelbaum R, et al. Primary spinal epidural lymphoma: patients’ profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study. Int J Radiat Oncol Biol Phys 2006;65:817–823.
  • Chang C, Chen H, Yang Y, et al. Surgical decompression improves recovery from neurological deficit and may provide a survival benefit in patients with diffuse large B-cell lymphoma-associated spinal cord compression: a case-series study. World J Surg Oncol 2013;11:90.
  • Flouzat-Lachaniette C, Allain J, Roudot-Thoraval F, et al. Treatment of spinal epidural compression due to hematological malignancies: a single institution's retrospective experience. Eur Spine J 2013;22:548–555.
  • Rathmell A, Gospodarowicz M, Sutcliffe S, et al. Localized extradural lymphoma: survival, relapse pattern and functional outcome. The Princess Margaret Hospital Lymphoma Group. Radiother Oncol 1992;24:14–20.
  • Wong E, Portlock C, O’Brien J, et al. Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. Neurology 1996;46:1543–1547.
  • Ferreri A, Assanelli A, Crocchiolo R, et al. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options. Hematol Oncol 2009;27:61–70.
  • Tilly H, Lepage E, Coiffier B, et al. Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma. Blood 2003;102:4284–4289.
  • Villa D, Connors J, Shenkier T, et al. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Ann Oncol 2010;21:1046–1052.
  • Zhang J, Chen B, Xu X. Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis. Leuk Lymphoma 2014;55:509–514.
  • Rubenstein J, Combs D, Rosenberg, et al. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 2003;101:466–468.
  • Boehme V, Schmitz N, Zeynalova S, et al. CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL). Blood 2009;113:3896–3902.
  • Snuderl M, Kolman OK, Chen YB, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol 2010;34:327–340.
  • Kumar A, Vanderplas A, Lacasce AS, et al. Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database. Cancer 2012;118:2944–2951.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.